Paper6090002
Serum amino acid levels in patients with hepatocellular carcinoma.
Watanabe A and 3 others. Cancer, 1984. Cited by 73 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Serum amino acid levels in patients with hepatocellular carcinoma. Papers, record 6090002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6090002
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acids | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Cirrhosis | Major topic |
| Liver Neoplasms | Major topic |
| Adult | |
| Aged | |
| Animals | |
| Colonic Neoplasms | |
| Ethionine | |
| Female | |
| Humans | |
| Liver Neoplasms, Experimental | |
| Male | |
| Middle Aged | |
| Rats | |
| Stomach Neoplasms |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769468 | The role and mechanism of CHST6-mediated lactation modification in lenvatinib resistance in hepatocellular carcinoma cells. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769468 | PubMed |
| 41849351 | Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer. | Cell Rep | 2026 | https://conductscience.org/library/papers/41849351 | PubMed |
| 41822356 | Machine learning-derived AS and AIS scores leverage BCAA metabolism and IL4I1 activity for prognosis and tailored therapy in ccRCC. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41822356 | PubMed |
| 40606917 | Diagnostic performance of Liver FibraChek Dx©, a blood-based test for the non-invasive detection of liver cirrhosis and cancer. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40606917 | PubMed |
| 39415432 | Associations between prediagnostic plasma metabolites and biliary tract cancer risk in the prospective UK Biobank cohort. | Am J Epidemiol | 2025 | https://conductscience.org/library/papers/39415432 | PubMed |
| 39006080 | Causal associations of BAFF-R on IgD+ CD24- B cell immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study. | J Cancer | 2024 | https://conductscience.org/library/papers/39006080 | PubMed |
| 38769521 | Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38769521 | PubMed |
| 38248814 | Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics. | Metabolites | 2023 | https://conductscience.org/library/papers/38248814 | PubMed |
| 38067430 | Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS). | Molecules | 2023 | https://conductscience.org/library/papers/38067430 | PubMed |
| 36612207 | Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612207 | PubMed |
| 36341373 | Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36341373 | PubMed |
| 35539509 | Combined spectroscopy methods and molecular simulations for the binding properties of trametinib to human serum albumin. | RSC Adv | 2018 | https://conductscience.org/library/papers/35539509 | PubMed |
| 35046467 | Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice. | Sci Rep | 2022 | https://conductscience.org/library/papers/35046467 | PubMed |
| 34605988 | The serum amino acid profile in COVID-19. | Amino Acids | 2021 | https://conductscience.org/library/papers/34605988 | PubMed |
| 34588983 | Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34588983 | PubMed |
| 34109436 | Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/34109436 | PubMed |
| 33882406 | Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data. | Lung Cancer | 2021 | https://conductscience.org/library/papers/33882406 | PubMed |
| 33796932 | Prognosis prediction of hepatocellular carcinoma after surgical resection based on serum metabolic profiling from gas chromatography-mass spectrometry. | Anal Bioanal Chem | 2021 | https://conductscience.org/library/papers/33796932 | PubMed |
| 33494351 | Cancers in Agreement? Exploring the Cross-Talk of Cancer Metabolomic and Transcriptomic Landscapes Using Publicly Available Data. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33494351 | PubMed |
| 32542016 | Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. | PLoS One | 2020 | https://conductscience.org/library/papers/32542016 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6090002
GET https://conductscience.org/api/papers/v1/6090002/cited_by?page=2